The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
Open accessAbstract
tPA is a clot-buster used to treat stroke, but if it's given too late after stroke onset, it can cause complications like hemorrhage. Daniel Lawrence and his colleagues show that a US Food and Drug Administration–approved kinase inhibitor, Gleevec, can prevent this side effect, thereby extending tPA's therapeutic window. Thrombolytic treatment of ischemic stroke with tissue plasminogen activator (tPA) is markedly limited owing to concerns about hemorrhagic complications and the requirement that tPA be administered within 3 h of symptoms. Here we report that tPA activation of latent platelet-derived growth factor-CC (PDGF-CC) may explain these limitations. Intraventricular injection of tPA or active PDGF-CC, in the absence of ischemia, leads to significant increases in cerebrovascular permeability. In contrast, co-injection of neutralizing antibodies to PDGF-CC with tPA blocks this increased permeability, indicating that PDGF-CC is a downstream substrate of tPA within the neurovascular unit. These effects are mediated through activation of PDGF-α receptors (PDGFR-α) on perivascular astrocytes, and treatment of mice with the PDGFR-α antagonist imatinib after ischemic stroke reduces both cerebrovascular permeability and hemorrhagic complications associated with late administration of thrombolytic tPA. These data demonstrate that PDGF signaling regulates blood-brain barrier permeability and suggest potential new strategies for stroke treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
Capdeville, R., Buchdunger, E., Zimmermann, J., & Matter, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd839 · Cited by 1,389
Larrue, V., von Kummer, R., Müller, A., & Bluhmki, E. (2001) · Stroke · doi:10.1161/01.str.32.2.438 · Cited by 1,006
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2109 · Cited by 880
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
Nicole, O., Docagne, F., Ali, C., Margaill, I., Carmeliet, P., MacKenzie, E. T., Vivien, D., & Buisson, A. (2001) · Nature Medicine · doi:10.1038/83358 · Cited by 735
Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator
Tsirka, S. E., Gualandris, A., Amaral, D. G., & Strickland, S. (1995) · Nature · doi:10.1038/377340a0 · Cited by 663
Wang, Y. F., Tsirka, S. E., Strickland, S., Stieg, P. E., Soriano, S. G., & Lipton, S. A. (1998) · Nature Medicine · doi:10.1038/nm0298-228 · Cited by 630
PDGF-C is a new protease-activated ligand for the PDGF α-receptor
Li, X., Pontén, A., Aase, K., Karlsson, L., Abramsson, A., Uutela, M., Bäckström, G., Hellström, M., Boström, H., Li, H., et al. (2000) · Nature Cell Biology · doi:10.1038/35010579 · Cited by 623
Self-citationTwo Classes of PDGF Receptor Eecognize Different Isoforms of PDGF
Hart, C. E., Forstrom, J. W., Kelly, J. D., Seifert, R. A., Smith, R. A., Ross, R., Murray, M. J., & Bowen-Pope, D. F. (1988) · Science · doi:10.1126/science.2836952 · Cited by 580
Yepes, M., Sandkvist, M., Moore, E. G., Bugge, T. H., Strickland, D. K., & Lawrence, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19212 · Cited by 566
Self-citationLipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator
Wang, X., Lee, S.-R., Arai, K., Lee, S.-R., Tsuji, K., Rebeck, G. W., & Lo, E. H. (2003) · Nature Medicine · doi:10.1038/nm926 · Cited by 460
Evolutionary Divergence of Platelet-Derived Growth Factor Alpha Receptor Signaling Mechanisms
Hamilton, T. G., Klinghoffer, R. A., Corrin, P. D., & Soriano, P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.4013-4025.2003 · Cited by 434
An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus
Tsirka, S. E., Rogove, A. D., Bugge, T. H., Degen, J. L., & Strickland, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00543.1997 · Cited by 430
Tissue Plasminogen Activator Reduces Neurological Damage After Cerebral Embolism
Zivin, J. A., Fisher, M., DeGirolami, U., Hemenway, C. C., & Stashak, J. A. (1985) · Science · doi:10.1126/science.3934754 · Cited by 380
Breedveld, P., Pluim, D., Cipriani, G., Wielinga, P., van Tellingen, O., Schinkel, A. H., & Schellens, J. H. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2416 · Cited by 351
Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis
Yepes, M., Sandkvist, M., Wong, M. K. K., Coleman, T. A., Smith, E., Cohan, S. L., & Lawrence, D. A. (2000) · Blood · doi:10.1182/blood.v96.2.569 · Cited by 278
Self-citationPlasminogen Activator Inhibitor-1 Regulates Tumor Growth and Angiogenesis
McMahon, G. A., Petitclerc, E., Stefansson, S., Smith, E., Wong, M. K. K., Westrick, R. J., Ginsburg, D., Brooks, P. C., & Lawrence, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105980200 · Cited by 263
Self-citationRole of Tissue Plasminogen Activator Receptor LRP in Hippocampal Long-Term Potentiation
Zhuo, M., Holtzman, D. M., Li, Y., Osaka, H., DeMaro, J., Jacquin, M., & Bu, G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00542.2000 · Cited by 258
Nagai, N., De Mol, M., Lijnen, H. R., Carmeliet, P., & Collen, D. (1999) · Circulation · doi:10.1161/01.cir.99.18.2440 · Cited by 252
A specific requirement for PDGF-C in palate formation and PDGFR-α signaling
Ding, H., Wu, X., Boström, H., Kim, I., Wong, N., Tsoi, B., O'Rourke, M., Koh, G. Y., Soriano, P., Betsholtz, C., et al. (2004) · Nature Genetics · doi:10.1038/ng1415 · Cited by 231
Self-citationMembrane depolarization induces calcium-dependent secretion of tissue plasminogen activator
Gualandris, A., Jones, T., Strickland, S., & Tsirka, S. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02220.1996 · Cited by 224
Tissue plasminogen activator is a potent activator of PDGF‐CC
Fredriksson, L., Li, H., Fieber, C., Li, X., & Eriksson, U. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600397 · Cited by 193
Self-citationTissue plasminogen activator in central nervous system physiology and pathology
Melchor, J. P., & Strickland, S. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0838 · Cited by 193
Molecular mechanisms of cerebral ischemia-induced neuronal death
Hou, S. T., & MacManus, J. P. (2002) · International Review of Cytology · doi:10.1016/s0074-7696(02)21011-6 · Cited by 184
Polavarapu, R., Gongora, M. C., Yi, H., Ranganthan, S., Lawrence, D. A., Strickland, D., & Yepes, M. (2007) · Blood · doi:10.1182/blood-2006-08-043125 · Cited by 174
Self-citationWillnow, T. E., & Herz, J. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.3.719 · Cited by 162
Pontén, A., Li, X., Thorén, P., Aase, K., Sjöblom, T., Östman, A., & Eriksson, U. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63694-2 · Cited by 154
Self-citationPawlak, R., Melchor, J. P., Matys, T., Skrzypiec, A. E., & Strickland, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406454102 · Cited by 148
Neuroserpin, a Neuroprotective Factor in Focal Ischemic Stroke
Cinelli, P., Madani, R., Tsuzuki, N., Vallet, P. G., Arras, M., Zhao, C. N., Osterwalder, T., Rülicke, T., & Sonderegger, P. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1028 · Cited by 133
Tabrizi, P., Wang, L., Seeds, N. W., McComb, J. G., Yamada, S., Griffin, J. H., Carmeliet, P., Weiß, M., & Zloković, B. V. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2801 · Cited by 129
Zhang, Z., Zhang, L., Yepes, M., Jiang, Q., Li, Q., Arniego, P., Coleman, T. A., Lawrence, D. A., & Chopp, M. (2002) · Circulation · doi:10.1161/01.cir.0000023942.10849.41 · Cited by 128
Self-citationYepes, M., Sandkvist, M., Coleman, T. A., Moore, E., Wu, J.-Y., Mitola, D. J., Bugge, T. H., & Lawrence, D. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14308 · Cited by 124
Self-citationThomalla, G., Sobesky, J., Köhrmann, M., Fiebach, J. B., Fiehler, J., Weber, O. Z., Krützelmann, A., Kucinski, T., Rosenkranz, M., Röther, J., et al. (2007) · Stroke · doi:10.1161/01.str.0000254565.51807.22 · Cited by 123
Yepes, M., Sandkvist, M., Coleman, T. A., Moore, E., Wu, J.-Y., Mitola, D. J., Bugge, T. H., & Lawrence, D. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214308 · Cited by 115
Self-citationYepes, M., & Lawrence, D. A. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422901103 · Cited by 69
Self-citationNAGAI, N., Suzuki, Y., HOEF, B. V., LIJNEN, H. R., & Collen, D. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01466.x · Cited by 66
Tissue-Type Plasminogen Activator and Neuroserpin: A Well-Balanced Act in the Nervous System?
Yepes, M., & Lawrence, D. A. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.03.004 · Cited by 64
Self-citationMarler, J. R., & Goldstein, L. B. (2003) · Science · doi:10.1126/science.1090270 · Cited by 64
LRP: a bright beacon at the blood-brain barrier
Herz, J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320337 · Cited by 63
Vora, N. A., Gupta, R. G., Thomas, A. J., Horowitz, M., Tayal, A. H., Hammer, M. D., Uchino, K., Wechsler, L. R., & Jovin, T. G. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0575 · Cited by 57
Yu, H., Schleuning, W.-D. D., Michl, M., Liberatore, G. T., Tan, S., & Medcalf, R. L. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01700.x · Cited by 18
(1992) · PubMed Central
Cited by
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Self-citationKang, S. H., Fukaya, M., Yang, J. K., Rothstein, J. D., & Bergles, D. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.009 · Cited by 787
Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans
Jickling, G. C., Liu, D., Stamova, B., Ander, B. P., Zhan, X., Lu, A., & Sharp, F. R. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.203 · Cited by 547
Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
Lakhan, S. E., Kirchgessner, A., Tepper, D., & Leonard, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00032 · Cited by 384
The PDGF/PDGFR pathway as a drug target
Papadopoulos, N., & Lennartsson, J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.11.007 · Cited by 283
Metadata
- Authors
- Su, E. J., Fredriksson, L., Geyer, M., Folestad, E., Cale, J., Andrae, J., Gao, Y., Pietras, K., Mann, K., Yepes, M., Strickland, D. K., Betsholtz, C., Eriksson, U., & Lawrence, D. A.
- Venue
- Nature Medicine
- Published
- 2008-06-22
- Volume
- 14
- Issue
- 7
- Pages
- 731-737
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1998907224
- Cited by
- 468
- References
- 43
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.